Literature DB >> 8976352

Endovascular aortounifemoral grafts and femorofemoral bypass for bilateral limb-threatening ischemia.

T Ohki1, M L Marin, F J Veith, R T Lyon, L A Sanchez, W D Suggs, J G Yuan, R A Wain, R E Parsons, A Patel, S P Rivers, J Cynamon, C W Bakal.   

Abstract

PURPOSE: Although axillobifemoral bypass procedures have a lower mortality rate than aortobifemoral bypass procedures, they are limited by decreased patency, moderate hemodynamic improvement, and the need for general anesthesia. This report describes an alternative approach to bilateral aortoiliac occlusive disease using unilateral endovascular aortofemoral bypass procedures in combination with standard femorofemoral reconstructions.
METHODS: Seven patients who had bilateral critical ischemia and tissue necrosis in association with severe comorbid medical illnesses underwent implantation of unilateral aortofemoral endovascular grafts, which were inserted into predilated, recanalized iliac arteries. The proximal end of the endovascular graft was fixed to the distal aorta or common iliac artery with a Palmaz stent. The distal end of the graft was suture-anastomosed to the ipsilateral patent outflow vessel, and a femorofemoral bypass procedure was then performed.
RESULTS: All endovascular grafts were successfully inserted through five occluded and two diffusely stenotic iliac arteries under either local (1), epidural (5), or general anesthesia (1). The mean thigh pulse volume recording amplitudes increased from 9 +/- 3 mm to 30 +/- 7 mm and from 6 +/- 2 mm to 26 +/- 4 mm ipsilateral and contralateral to the aortofemoral graft insertion, respectively. In all cases the symptoms completely resolved. Procedural complications were limited to one local wound hematoma. No graft thromboses occurred during follow-up to 28 months (mean, 17 months).
CONCLUSIONS: Endovascular iliac grafts in combination with standard femorofemoral bypass grafts may be an effective alternative to axillobifemoral bypass in high-risk patients who have diffuse aortoiliac occlusive disease, particularly when bilateral axillary-subclavian disease is present.

Entities:  

Mesh:

Year:  1996        PMID: 8976352     DOI: 10.1016/s0741-5214(96)70044-7

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  5 in total

1.  Increasing incidence of midterm and long-term complications after endovascular graft repair of abdominal aortic aneurysms: a note of caution based on a 9-year experience.

Authors:  T Ohki; F J Veith; P Shaw; E Lipsitz; W D Suggs; R A Wain; M Bade; M Mehta; N Cayne; J Cynamon; J Valldares; J McKay
Journal:  Ann Surg       Date:  2001-09       Impact factor: 12.969

2.  Analysis of endovascular graft treatment for aortoiliac occlusive disease: what is its role based on midterm results?

Authors:  R A Wain; F J Veith; M L Marin; T Ohki; W D Suggs; J Cynamon; J Goldsmith; L A Sanchez
Journal:  Ann Surg       Date:  1999-08       Impact factor: 12.969

3.  Endovascular grafts and other image-guided catheter-based adjuncts to improve the treatment of ruptured aortoiliac aneurysms.

Authors:  T Ohki; F J Veith
Journal:  Ann Surg       Date:  2000-10       Impact factor: 12.969

4.  Adverse outcome following transfemoral endovascular stent-graft repair of an abdominal aortic aneurysm in a patient with severe liver dysfunction: report of a case.

Authors:  N Ohara; T Miyata; H Oshiro; H Shigematsu; T Ohki
Journal:  Surg Today       Date:  2000       Impact factor: 2.549

5.  The impact of adjunctive iliac stenting on femoral-femoral bypass in contemporary practice.

Authors:  Chetan P Huded; Philip P Goodney; Richard J Powell; Brian W Nolan; Eva M Rzucidlo; Samuel T Simone; Daniel B Walsh; David H Stone
Journal:  J Vasc Surg       Date:  2012-01-05       Impact factor: 4.268

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.